OWC Pharmaceutical Research Corp. (OTCMKTS:OWCP) Files An 8-K Other Events

0

OWC Pharmaceutical Research Corp. (OTCMKTS:OWCP) Files An 8-K Other Events
Item 8.01. Other Events.

OWC Pharmaceutical Research Corp. (the "Registrant"), is filing with this Form 8-K, a Letter to Shareholders from our Chairman, Dr. Stanley Hirsch, a copy of which is attached hereto as Exhibit 99.1 and is dated and will be published tomorrow, September 14, 2017.

Item 9.01 Financial Statements and Exhibits.

(a) The following documents are filed as exhibits to this report on Form 8-K or incorporated by reference herein. Any document incorporated by reference is identified by a parenthetical reference to the SEC filing that included such document.

Exhibit No.

Description
99.1 Chairman's Letter to Shareholders dated September 14, 2017, filed herewith.


OWC Pharmaceutical Research Corp. Exhibit
EX-99 2 exh99_1.htm EXHIBIT 99.1 Exhibit 99 Exhibit 99.1 September 14,…
To view the full exhibit click here

About OWC Pharmaceutical Research Corp. (OTCMKTS:OWCP)

OWC Pharmaceutical Research Corp. is a medical cannabis research and development company. The Company is engaged in the research and development of cannabis-based medical products (the Product Prospects) for the treatment of multiple myeloma, psoriasis and fibromyalgia, as well as development of a cannabis soluble tablet delivery system that has applications for other indications. The Company also provides consulting services to governmental and private entities to assist them with developing and implementing various medical cannabis programs. As of September 30, 2016, the Company was engaged in two business activities: work with GUMI to commercialize and market the Company’s Electromagnetic Percussion Device (the Device), and research and development of Cannabis-based medical products for the treatment of a range of medical conditions and/or diseases, such as multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD) migraines and a delivery system.

OWC Pharmaceutical Research Corp. (OTCMKTS:OWCP) Recent Trading Information

OWC Pharmaceutical Research Corp. (OTCMKTS:OWCP) closed its last trading session down -0.011 at 0.288 with 920,869 shares trading hands.